Literature DB >> 7858645

HIV/AIDS and its interaction with tuberculosis in Latin America and the Caribbean.

F Zacarías1, R S González, P Cuchí, A Yáñez, A Peruga, R Mazín, C Betts, M Weissenbacher.   

Abstract

At present, human immunodeficiency virus (HIV) is thought to have infected over 17 million people worldwide, over 1 million in North America and roughly 2 million in Latin America and the Caribbean. By comparison, infection with the tuberculosis (TB) agent Mycobacterium tuberculosis is far more common, current estimates indicating that roughly one-third of the world's population is infected. These two infections tend to aggravate each other. That is, HIV leads to a progressive immune system depression that favors reactivation of TB in people with latent tuberculous infections; it promotes progression of TB primary infections or reinfections to full-blown tuberculous disease; and it fosters TB transmission, because those simultaneously infected with HIV and M. tuberculosis tend to develop a bacilliferous and contagious TB that can be transmitted to other susceptible individuals, even though the latter are HIV-negative. In addition, this coinfection tends to promote circulation of drug-resistant M. tuberculosis and to produce peculiar manifestations that complicate TB diagnosis, treatment, and control. Overall, it seems clear that the growing threat posed by these associated agents demands effective action in the form of well-coordinated measures involving throughgoing participation by all countries.

Entities:  

Mesh:

Year:  1994        PMID: 7858645

Source DB:  PubMed          Journal:  Bull Pan Am Health Organ        ISSN: 0085-4638


  1 in total

1.  Emergence of Vancomycin-Resistant Enterococcus faecium at an Australian Hospital: A Whole Genome Sequencing Analysis.

Authors:  Kelvin W C Leong; Louise A Cooley; Tara L Anderson; Sanjay S Gautam; Belinda McEwan; Anne Wells; Fiona Wilson; Lucy Hughson; Ronan F O'Toole
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.